Geopolitical risk in pharmaceutical supply chains in 2026

AI Summary

The pharmaceutical industry is expected to face significant geopolitical risks by 2026, including potential disruptions in supply chains. These challenges could lead to continuity loss and compliance issues, affecting market access for various companies.

Pharmaceutical companies face increased risks of continuity loss, delayed market access, and compliance breaches – significantly impacting ...